|
AU2008201049A1
|
|
Lens delivery system
|
|
CA2623906A1
|
|
Intraocular lens
|
|
US2008153903A1
|
|
Inhibitors of protein kinase c-delta for the treatment of glaucoma
|
|
WO2008070513A1
|
|
Modulation of polysialylated neural adhesion molecules (psa-ncam) as a regulator of ocular disease
|
|
US2008139531A1
|
|
Use of connective tissue mast cell stabilizers to facilitate ocular surface re-epithelization and wound repair
|
|
US2008214486A1
|
|
RNAi-MEDIATED INHIBITION OF AQUAPORIN 4 FOR TREATMENT OF IOP-RELATED CONDITIONS
|
|
US2008114076A1
|
|
Punctal plug comprising a water-insoluble polymeric matrix
|
|
CN101553207A
|
|
Punctal plug comprising a water-insoluble polymeric matrix
|
|
US2008093247A1
|
|
Packaging materials for formulations containing 2-pyrrolidone derivatives
|
|
TW200824739A
|
|
Ophthalmic injection method
|
|
TW200824664A
|
|
Ophthalmic injection system
|
|
CN101663053A
|
|
Have unique indigo plant-purple by with the intraocular lens of blue light transmissison characteristic
|
|
CN101605516A
|
|
Drug casting
|
|
CN101522171A
|
|
Self-preserved aqueous pharmaceutical compositions
|
|
US2008057072A1
|
|
Antagonists of ci-m6p/igf2r for prevention and treatment of ctgf-mediated ocular disorders
|
|
CA2596760A1
|
|
Lens delivery system
|
|
WO2008016989A1
|
|
Process for preparing pyranoindazole serotonergic receptor agonists
|
|
WO2008016993A1
|
|
Intermediates and methods for serotonergic agonist synthesis
|
|
TW200816966A
|
|
Low-tack ophthalmic and otorhinolaryngological device materials
|
|
TW200808360A
|
|
RNAi-mediated inhibition of spleen tyrosine kinase-related inflammatory conditions
|
